跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,025 条关于
“Dawson James Securities”
全部
2,025
临床试验
406
药物
13
机构
81
资讯
1,525
去年
Oragenics Announces Termination of President's Employment Agreement and Provides Business Update
去年
Oragenics Raises $20 Million to Advance Concussion Treatment Clinical Trials
去年
Profusa Goes Public on Nasdaq with Tissue-Integrating Biosensor Platform for Chronic Disease Management
7个月前
Roche Appoints Cancer Researcher Mark Dawson to Lead Pharma Research Division
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
12天前
OSUCCC–James Appoints D. Neil Hayes to Lead Precision Cancer Medicine Institute
去年
Alnylam's Amvuttra Poised to Become First-Line ATTR-CM Treatment
去年
Agios Pharmaceuticals Faces Securities Fraud Investigation Following FDA Delay of PYRUKYND Approval
第 1 页,共 153 页
上一页
下一页